HHS scraps 340B rebate pilot in win for hospitals

Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.

AI Summary: Federal health officials have reversed course on a highly controversial 340B rebate pilot program after federal courts blocked its implementation – a move hailed by providers as a long‐awaited relief from cash flow and administrative burdens.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

AbbVie sues over Botox selection in Medicare price negotiations / 3 months

HHS drops 340B pilot following court rulings / 3 months

FTC settles insulin lawsuit forces Express Scripts policy changes / 3 months

Judge blocks 340B drug pricing pilot program implementation / 4 months

CMS Unveils Medicaid Drug Pricing Model with Most-Favored Nation Approach / 6 months

Optum Rx/Caremark and FTC edge toward settlement in insulin case / 2 months

Life-extending prostate cancer drug to be offered to thousands in England / 4 months